Brainstorm Cell Therapeutics Inc. SEC filings BCLI
Brainstorm Cell Therapeutics Inc. has 949 filings in SEC EDGAR's recent list, going back to May 24, 2001. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 14, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 2, 2026 | — |
| CORRESP | Letter to the SEC | Jun 1, 2026 | — |
| UPLOAD | Letter from the SEC | May 27, 2026 | — |
| 25-NSE | Delisting notice | Oct 9, 2025 | — |
| RW | Filing | Jul 22, 2025 | — |
| EFFECT | Filing | Sep 27, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| CORRESP | Letter to the SEC | Sep 24, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2024 | — |
| EFFECT | Filing | Sep 6, 2024 | — |
| CORRESP | Letter to the SEC | Sep 4, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2024 | — |
| PRER14A | Filing | Aug 6, 2024 | — |
| EFFECT | Filing | Aug 19, 2021 | — |
| CORRESP | Letter to the SEC | Aug 17, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 16, 2021 | — |
| EFFECT | Filing | Aug 30, 2019 | — |
| CORRESP | Letter to the SEC | Aug 28, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2019 | — |
| D | Filing | Aug 9, 2019 | — |
| EFFECT | Filing | Sep 28, 2018 | — |
| CORRESP | Letter to the SEC | Sep 21, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2018 | — |
| EFFECT | Filing | Jun 29, 2018 | — |
| CORRESP | Letter to the SEC | Jun 27, 2018 | — |
| D | Filing | Jun 20, 2018 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2018 | — |
| EFFECT | Filing | Nov 21, 2016 | — |
| EFFECT | Filing | Jun 10, 2015 | — |
| CORRESP | Letter to the SEC | Jun 10, 2015 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2015 | — |
| EFFECT | Filing | May 27, 2015 | — |
| EFFECT | Filing | May 1, 2015 | — |
| EFFECT | Filing | Feb 10, 2015 | — |
| EFFECT | Filing | Feb 10, 2015 | — |
| D | Filing | Jan 21, 2015 | — |
| CERTNAS | Auto-generated paper document | Sep 24, 2014 | — |
| 8-A12B | Filing | Sep 24, 2014 | — |
| EFFECT | Filing | Jul 24, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2014 | — |
| CORRESP | Letter to the SEC | Jul 21, 2014 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2014 | — |
| D | Filing | Jul 1, 2014 | — |
| D | Filing | May 9, 2014 | — |
| EFFECT | Filing | Aug 12, 2013 | — |
| CORRESP | Letter to the SEC | Aug 6, 2013 | — |
| CORRESP | Letter to the SEC | Aug 6, 2013 | — |
| CORRESP | Letter to the SEC | Aug 5, 2013 | — |
| CORRESP | Letter to the SEC | Mar 20, 2013 | — |
| UPLOAD | Letter from the SEC | Mar 12, 2013 | — |
| CORRESP | Letter to the SEC | Mar 12, 2013 | — |
| UPLOAD | Letter from the SEC | Mar 8, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 20, 2013 | — |
| D | Filing | Jul 27, 2012 | — |
| EFFECT | Filing | Jul 13, 2012 | — |
| CORRESP | Letter to the SEC | Jul 11, 2012 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2012 | — |
| CORRESP | Letter to the SEC | Feb 27, 2012 | — |
| UPLOAD | Letter from the SEC | Feb 14, 2012 | — |
| UPLOAD | Letter from the SEC | Jan 12, 2012 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2011 | — |
| CORRESP | Letter to the SEC | Nov 9, 2011 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2011 | — |
| 8-A12G | Filing | Apr 26, 2011 | — |
| DEFR14A | Filing | May 3, 2010 | — |
| NT 10-Q | Filing | Aug 14, 2009 | Jun 30, 2009 |
| NT 10-K | Filing | Apr 1, 2009 | Dec 31, 2008 |
| NT 10-Q | Filing | Nov 17, 2008 | Sep 30, 2008 |
| 10KSB | Filing | Apr 14, 2008 | Dec 31, 2007 |
| NT 10-K | Filing | Mar 31, 2008 | Dec 31, 2007 |
| 10QSB | Filing | Nov 13, 2007 | Sep 30, 2007 |
| 10QSB | Filing | Aug 20, 2007 | Jun 30, 2007 |
| NT 10-Q | Filing | Aug 14, 2007 | Jun 30, 2007 |
| 10QSB | Filing | May 15, 2007 | Mar 31, 2007 |
| 10KSB | Filing | Mar 30, 2007 | Dec 31, 2006 |
| 10QSB | Filing | Nov 14, 2006 | Sep 30, 2006 |
| 10QSB | Filing | Aug 17, 2006 | Jun 30, 2006 |
| NT 10-Q | Filing | Aug 15, 2006 | Jun 30, 2006 |
| 10KSB | Filing | Jun 29, 2006 | Mar 31, 2006 |
| UPLOAD | Letter from the SEC | Mar 13, 2006 | — |
| CORRESP | Letter to the SEC | Mar 7, 2006 | — |
| CORRESP | Letter to the SEC | Feb 21, 2006 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2006 | — |
| 10QSB | Filing | Feb 6, 2006 | Dec 31, 2005 |
| 10QSB | Filing | Nov 21, 2005 | Sep 30, 2005 |
| NT 10-Q | Filing | Nov 15, 2005 | Sep 30, 2005 |
| 10QSB | Filing | Aug 10, 2005 | Jun 30, 2005 |
| 10KSB | Filing | Jun 7, 2005 | Mar 31, 2005 |
| 10QSB | Filing | Feb 14, 2005 | Dec 31, 2004 |
| 10QSB/A | Filing | Dec 7, 2004 | Jun 30, 2004 |
| 10KSB/A | Filing | Dec 7, 2004 | Mar 31, 2004 |
| REGDEX | Auto-generated paper document | Nov 24, 2004 | — |
| UPLOAD | Letter from the SEC | Nov 22, 2004 | — |
| 10QSB | Filing | Nov 15, 2004 | Sep 30, 2004 |
| 10QSB/A | Filing | Oct 26, 2004 | Jun 30, 2004 |
| 10QSB | Form 10-qsb | Aug 17, 2004 | Jun 30, 2004 |
| NT 10-Q | Filing | Aug 17, 2004 | Jun 30, 2004 |
| 10KSB | Filing | Jun 14, 2004 | Mar 31, 2004 |
| 10QSB | Filing | Feb 10, 2004 | Dec 31, 2003 |
| 10QSB | Filing | Oct 16, 2003 | Sep 30, 2003 |
| 10QSB | Filing | Aug 8, 2003 | Jun 30, 2003 |
| 10KSB | Filing | Jun 27, 2003 | Mar 31, 2003 |
| 10QSB/A | Filing | Mar 3, 2003 | Sep 30, 2002 |
| 10QSB/A | Filing | Mar 3, 2003 | Jun 30, 2002 |
| 10KSB/A | Filing | Mar 3, 2003 | Mar 31, 2002 |
| 10QSB | Filing | Feb 13, 2003 | Dec 31, 2002 |
| 10QSB/A | Filing | Nov 14, 2002 | Sep 30, 2002 |
| 10QSB/A | Filing | Nov 14, 2002 | Jun 30, 2002 |
| 10KSB/A | Filing | Nov 14, 2002 | Mar 31, 2002 |
| 10QSB | Filing | Oct 30, 2002 | Sep 30, 2002 |
| 10QSB | Filing | Jul 30, 2002 | Jun 30, 2002 |
| 10KSB | Filing | May 7, 2002 | Mar 31, 2002 |
| 10QSB | Filing | Feb 8, 2002 | Dec 31, 2001 |
| 10QSB | Filing | Nov 8, 2001 | Sep 30, 2001 |
Showing 114 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BCLI (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1137883
- Former names
- BRAINSTORM CELL THERAPEUTICS INC (until Jul 23, 2012); GOLDEN HAND RESOURCES INC (until Nov 22, 2004); WIZBANG TECHNOLOGIES INC (until Aug 8, 2003)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.